Lewis A. Opler

Lewis A. Opler's AcademicInfluence.com Rankings

Lewis A. Opler

Biology

#8564

World Rank

#11662

Historical Rank

biology Degrees

Download Badge

Biology

Lewis A. Opler's Degrees

Doctorate Medicine Columbia University
PhD Psychiatry Columbia University

Why Is Lewis A. Opler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Lewis A. Opler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The positive and negative syndrome scale (PANSS) for schizophrenia. (1987) (18374)
Reliability and validity of the positive and negative syndrome scale for schizophrenics (1988) (964)
The Positive and Negative Syndrome Scale (PANSS): Rationale and Standardisation (1989) (959)
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. (1997) (357)
Risk factors for long-term homelessness: findings from a longitudinal study of first-time homeless single adults. (2005) (318)
Significance of Positive and Negative Syndromes in Chronic Schizophrenia (1986) (201)
Risk factors for homelessness among schizophrenic men: a case-control study. (1994) (182)
Positive and Negative Syndromes in Chronic Schizophrenic Inpatients (1984) (142)
Treatment of schizophrenia 1999 (1999) (136)
The positive-negative dimension in schizophrenia: its validity and significance. (1987) (125)
Risk factors for homelessness among women with schizophrenia. (1995) (118)
Neurological signs and the positive-negative dimension in schizophrenia (1990) (117)
Akathisia, suicidality, and fluoxetine. (1992) (110)
Positive and negative syndromes in schizophrenia as a function of chronicity (1986) (98)
Amantadine in the treatment of neuroendocrine side effects of neuroleptics. (1987) (83)
A critical time intervention with mentally ill homeless men: impact on psychiatric symptoms. (2000) (81)
Risk factors for homelessness among indigent urban adults with no history of psychotic illness: a case-control study. (2000) (81)
The role of pimozide in clinical psychiatry: a review. (1991) (79)
Positive and negative subtypes in acute schizophrenia. (1984) (73)
SCID-PANSS: two-tier diagnostic system for psychotic disorders. (1991) (71)
Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis. (1994) (64)
Pharmacotherapy of post-traumatic stress disorder. (2006) (62)
A single‐dose, randomized, double‐blind, placebo‐controlled trial of sublingual asenapine for acute agitation (2014) (61)
Visual Information Processing in Positive, Mixed, and Negative Schizophrenic Syndromes (1990) (56)
Management of schizophrenia with obsessive-compulsive features. (2009) (55)
Dot Enumeration Perceptual Organization Task (DEPOT): evidence for a short-term visual memory deficit in schizophrenia. (1996) (54)
Mediation by cyclic AMP of hormone-stimulated glycogenolysis in cultured rat astrocytoma cells. (1972) (53)
Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping (1987) (53)
Correlates of codisorders in homeless and never homeless indigent schizophrenic men (1994) (52)
The American Psychiatric Publishing Textbook of Schizophrenia (2006) (43)
Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia (2015) (39)
Symptom Profiles and Homelessness in Schizophrenia (1994) (38)
Pimozide treatment of the negative schizophrenic syndrome: an open trial. (1988) (36)
Attention deficit disorder psychosis as a diagnostic category. (1987) (33)
Schizophrenia with Obsessive-Compulsive Features: Assessment and Treatment (1994) (33)
Evaluation in an inpatient setting of DTREE, a computer-assisted diagnostic assessment procedure. (1993) (31)
Management of Schizophrenia With Obsessive-Compulsive Disorder (2000) (31)
EEG biofeedback treatment of ADD. A viable alternative to traditional medical intervention? (2001) (31)
L-DOPA in the Treatment of Negative Schizophrenic Symptoms: A Single-Subject Experimental Study (1986) (30)
High-dose naloxone in tardive dyskinesia (1988) (27)
Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish (2015) (24)
Negative symptom rating scale: Limitations in psychometric and research methodology (1986) (20)
Psychopharmacologic treatment of negative schizophrenic symptoms. (1994) (20)
Long-term impact of web-based tools, leadership feedback, and policies on inpatient antipsychotic polypharmacy. (2011) (19)
Simple schizophrenia, negative symptoms, and prefrontal hypodopaminergia. (1992) (19)
Impact of Smoking Cessation on Psychiatric Inpatients Treated with Clozapine or Olanzapine (2010) (17)
Pharmacologic treatment of delusions. (1995) (17)
Comorbid: Posttraumatic stress disorder and schizophrenia (2005) (17)
Symptom-Specific Group Therapy for Inpatients with Schizophre n i a (2001) (17)
Pharmacotherapy of cognitive deficits in schizophrenia (2013) (17)
The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors. (1989) (16)
Safety Evaluation of the Concomitant Use of Clozapine and Benzodiazepines: A Retrospective, Cross-Sectional Chart Review (2008) (15)
Psychostimulants in the Treatment of Adults with Psychosis and Attention Deficit Disorder (2001) (14)
Negative schizophrenic symptoms are associated with backward masking vulnerability (1990) (14)
Maximizing clozapine utilization while minimizing blood dyscrasias: evaluation of patient demographics and severity of events (2016) (13)
Return of menstruation after switching from risperidone to olanzapine. (1998) (13)
Birth seasonality and schizophrenia. (1985) (13)
Positive and negative subtypes in schizophrenia. (1987) (12)
Rethinking Medication Prescribing Practices in an Inner-City Hispanic Mental Health Clinic (2004) (12)
Hematologic impact of antibiotic administration on patients taking clozapine. (2012) (12)
Activation Symptoms and Discharge in Elderly Chronic Schizophrenic Inpatients (2004) (11)
Impairment in emotional modulation of attention and memory in schizophrenia (2014) (11)
Exploring the Potential Effect of Polypharmacy on the Hematologic Profiles of Clozapine Patients (2014) (11)
Integrating psychopharmacology and cognitive remediation to treat cognitive dysfunction in the psychotic disorders (2013) (10)
Sex differences in hedonic judgement of odors in schizophrenia cases and healthy controls (2018) (10)
Sertraline and akathisia. (1994) (10)
Validation of the Russian Version of the Positive and Negative Syndrome Scale (PANSS-Ru) and Normative Data. (2018) (9)
The Evolving Brain: The Known and The Unknown (2007) (9)
Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS) (2017) (9)
Genetics of schizophrenia and the positive-negative dimension. (1985) (8)
Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics. (1986) (8)
Schizophrenia: A Multidimensional Disorder (1994) (8)
Effects of Statins and Cholesterol on Patient Aggression: Is There a Connection? (2018) (8)
Use of the Positive and Negative Syndrome Scale (PANSS) in Clinical Practice (1998) (7)
The Symptoms of Trauma Scale (SOTS): Psychometric evaluation and gender differences with adults diagnosed with serious mental illness (2016) (7)
Neurocognitive features of chronic schizophrenic inpatients. (1991) (7)
Combined mesoridazine and amantadine treatment in refractory schizophrenics (1985) (6)
Physician Prescribing Practices of Vitamin D in a Psychiatric Hospital. (2016) (6)
Abnormal phospholipid metabolism in schizophrenia: evidence from epidemiological findings, clinical observations, and preliminary clinical trials. (2001) (5)
The changing presentation of catatonia. (1987) (5)
Reducing guesswork in schizophrenia treatment (2006) (5)
Deficit or negative syndrome? (1989) (5)
Multimedia Reviews: The Culture of Emotions: A Cultural Competence and Diversity Training Program (2002) (5)
Fluoxetine and Preoccupation With Suicide (1991) (4)
Management of Schizophrenia with: Obsessive-Disorder Compulsive (2005) (4)
Serotonergic agents and frontal lobe syndrome. (1994) (4)
Comorbidities in Schizophrenia: Challenges for Researchers and Clinicians (2013) (3)
The Symptoms of Trauma Scale (SOTS): An Initial Psychometric Study (2015) (3)
Dilapidation in schizophrenia: Relationship to negative syndrome and prefrontal impairment (1990) (3)
FLUOXETINE AND PREOCCUPATION WITH SUICIDE. REPLY (1991) (3)
Relationship between Neuroleptic Dose and Positive and Negative Symptoms (1994) (3)
Transcending Psychosis: The Complexity of Comorbidity in Schizophrenia. (2016) (3)
Zonisamide-induced psychosis in a patient with bipolar disorder and narcolepsy. (2014) (3)
Reflections on "Emil Kraepelin: Icon and Reality". (2016) (2)
Information processing deficit in schizophrenia: a frontal lobe sign? (1989) (2)
Tardive dyskinesia and institutional practice: current issues and guidelines. (1980) (2)
Cognitive deficits in affective disorders and schizophrenia. (1995) (2)
CONCEPTUALIZING ADHD. AUTHOR'S REPLIES (1994) (2)
Conducting clinical psychiatric research in "non-research" settings. (1994) (2)
The possible role of dopamine autoreceptors in neuroleptic atypicality. (1988) (2)
Alprazolam in the treatment of bulimia. (1986) (2)
Abnormalities in the brain and schizophrenia. (1990) (1)
This Issue: Managing Comorbidities in Schizophrenia (2005) (1)
New Agents for Treating Negative Symptoms (1995) (1)
Drug interaction review in a psychiatric population (2017) (1)
Antipsychotic Drugs and Interactions: Implications for Criminal and Civil Litigation (2012) (1)
Neuroendocrine Side Effects of Neuroleptics (1988) (1)
Oseltamivir use in psychiatric inpatients taking clozapine: effect on neuropsychiatric events. (2011) (1)
Pain insensitivity and affective flattening in schizophrenia (1993) (1)
INFLUENCE OF ERGOT DERIVATIVES ON THE DIFFERENT TYPES OF DOPAMINE RECEPTORS AND ON OTHER AMINE RECEPTORS IN PRIMATE BRAIN (1979) (1)
Imipramine and Clonazepam for Panic Disorder (1989) (1)
FLUOXETINE-DOPAMINERGIC INTERACTION DATA. AUTHORS' REPLY (1994) (1)
Codisorders and homelessness in schizophrenia: Gender differences (1993) (0)
Cognitive Symptoms in Schizophrenia Recognizing and Treating Cognitive Deficits in Schizophrenia (2009) (0)
Dear Family Members and Healthcare Providers (2007) (0)
A POSITIVE AND NEGATIVE SYMPTOM SCALE FOR CHILDREN AND ADOLESCENTS: THE KIDDIE‐PANSS (1992) (0)
Pimozide-induced depression? (1993) (0)
Synopsis of neuropsychiatry (1995) (0)
Pentoxifylline and panic attacks. (1994) (0)
Neuroleptic effects on positive and negative phenomenology in schizophrenia (1993) (0)
Crisis intervention services to the Lubavitch community following the Brooklyn Bridge shooting: A public-private collaboration (1999) (0)
Rating Scales for Psychiatric Disorders (2016) (0)
Schizophrenia and clozapine treatment. (1993) (0)
Adjunctive Sarcosine and N-Acetylcysteine Use for Treatment-Resistant Schizophrenia (2018) (0)
Comparative validity of alternative systems for interpretation of PANSS rated symptoms of schizophrenia (2003) (0)
Response to letter from Khan et al. (2015) (0)
Caton et al. Respond [2] (2006) (0)
Beyond Principal-Component Analysis of the Positive and Negative Syndrome Scale in Patients with Schizophrenia (2002) (0)
Conceptualizing ADHD. (1994) (0)
Novel Antipsychotic Drugs (1993) (0)
Clinical and Neurobiological Advances in Psychiatry, Volume 1: Advances in the Neurobiology of Schizophrenia (1996) (0)
Re: The Combined Use of Atypical Antipsychotics and Cognitive-Behavioural Therapy in Schizophrenia (2003) (0)
Contents of The Journal of Nervous and Mental Disease (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Lewis A. Opler?

Lewis A. Opler is affiliated with the following schools:

Columbia University